NextGen delves further inpatient EDI market with ViaTrack purchase

Justine Varieur Cadet | | Health Exec | EMR/EHR
Quality Systems, an Irvine, Calif.-based developer of healthcare information systems and connectivity technologies, has entered into an agreement to acquire ViaTrack Systems, a developer of IT for electronic data interchange (EDI) offerings.

ViaTrack has been a long-time EDI partner of Quality Systems’ wholly owned subsidiary, NextGen Healthcare. Augusta, Ga.-based ViaTrack will become part of Quality Systems, continuing to support NextGen’s ambulatory clients, while also allowing NextGen to leverage ViaTrack’s infrastructure and technical tools to offer EDI services to its inpatient clients.

The acquisition of ViaTrack allows NextGen to expand its presence in the inpatient EDI market.



Justine Varieur Cadet

Related Content

Academic health system working on AI dictation feature for Epic
Gottlieb: Let’s not slap the label ‘medical device’ on AI software that only helps clinicians make care decisions
PHOTO GALLERY: The Epic intergalactic headquarters art collection
AI brings cardiology, neurology teams together to boost care for stroke patients
Best in KLAS: End-users review top health IT systems in the US
More than words: AI takes NLP to the next level to identify signs of heart failure

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.